[Skip to Content]
[Skip to Content Landing]
From the JAMA Network
January 5, 2016

Computed Tomography Screening for Lung CancerA High-Value Proposition?

Author Affiliations
  • 1Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
  • 2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington
  • 3Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;315(1):77-78. doi:10.1001/jama.2015.17877

High-quality evidence shows that low-dose chest computed tomography (CT) screening effectively reduces lung cancer–related deaths in patients who smoked heavily.1 Compared with many other cancer screening modalities, this approach will be expensive,2 but whether it will be cost-effective is unknown. In the September 2015 issue of JAMA Oncology, Goffin et al3 estimate the cost-effectiveness of CT screening for lung cancer in Canada. This study is timely because it comes in the wake of the US National Lung Screening Trial (NSLT) and widespread availability of CT screening insurance coverage in the United States. The Canadian government has not yet implemented CT screening and often considers cost-effectiveness prior to making coverage decisions for new technologies.4

First Page Preview View Large
First page PDF preview
First page PDF preview